Many neuropsychiatric disorders are thought to result from subtle changes in neural circuit formation. We used human embryonic stem cells and induced pluripotent stem cells (hiPSCs) to model mature, post-mitotic excitatory neurons and examine effects of fibroblast growth factor 2 (FGF2). FGF2 gene expression is known to be altered in brain regions of major depressive disorder (MDD) patients and FGF2 has antidepressive effects in animal models of depression. We generated stable inducible neurons (siNeurons) conditionally expressing human neurogenin-2 (NEUROG2) to generate a homogenous population of post-mitotic excitatory neurons and study the functional as well as the transcriptional effects of FGF2. Upon induction of NEUROG2 with doxycycline, the vast majority of cells are post-mitotic, and the gene expression profile recapitulates that of excitatory neurons within 6 days.
Major depressive disorder (MDD) is one of the most common psychiatric disorders affecting about 28% of the US population during their lifetime (Vandeleur et al. 2017) . Because of the clinical and genetic heterogeneity of MDD, its pathophysiology remains elusive (Tanti and Belzung 2010) . Previous research has demonstrated that alterations in various neurotransmitters such as serotonin as well as neurotrophic factors such as brain-derived neurotrophic factors contribute to MDD (Duman and Aghajanian 2012) . More recently, reduced glutamatergic signaling has been linked to MDD (Eisch and Petrik 2012) . Brain imaging of MDD patients suggests a volume reduction in hippocampus, dorsolateral prefrontal cortex, and anterior cingulate cortex (Sacher et al. 2012) . Post-mortem analyses of these same brain regions implicate several genes correlating with MDD but the most significantly dysregulated genes in MDD patients belong to the fibroblast growth factor (FGF) family (Turner et al. 2016) . Microarray hybridization studies of the dorsolateral prefrontal cortex region of MDD patients show that the ligand FGF9 is up-regulated relative to controls while the ligand FGF2 and the FGF receptors (FGFR2 and FGFR3) are down-regulated (Evans et al. 2004) .
Animal studies using various models of depression in rodents have shown anti-depressant effects of FGF2 (Jarosik et al. 2011) . Rats undergoing social defeat stress showed decreased hippocampal FGF2 expression and administration of FGF2 reversed the behavioral correlates of depression (Elsayed et al. 2012) . Furthermore, treatment of adult rats with anti-depressants resulted in increased FGF2 expression in cerebral cortex and hippocampus (Mallei et al. 2002; Bachis et al. 2008) . FGF2 knockout mice displayed increased anxiety and the phenotype was completely rescued upon treatment with FGF2 in adulthood (Salmaso et al. 2016) . It has also been established that FGF2 treatment of rat cortical neurons enhances of glutamatergic signaling (Li et al. 2002) . These reports together implicate a role for FGF2 regulation of fully developed neurons in mediating antidepressant effect.
FGF2 is the most abundant ligand in the developing brain (Vaccarino et al. 1999; Ford-Perriss et al. 2001 ) and the human genome contains 22 genes encoding FGF ligands as well as four genes encoding receptors, most of which are expressed in the developing nervous system (Guillemot and Zimmer 2011) . All four FGFR genes encode single transmembrane protein with extracellular immunoglobulin domain and intracellular tyrosine kinase domains. The binding of an FGF ligand to an FGFR causes dimerization resulting in autophosphorylation and activation of four major intracellular pathways: Ras/MAP kinase, phospholipase C/ protein kinase A, signal transducer and activator of transcription, and/or PI3 kinase signaling pathway. Once activated, these pathways phosphorylate transcription factors to alter the expression of FGF-dependent genes (Ornitz and Itoh 2015) .
In order to better understand the specific role of FGF2 in human neuronal function, we investigated the global transcriptional effects of FGF2 in post-mitotic human glutamatergic neurons and the signaling mechanisms that control these transcriptional changes. We generated doxycycline (dox)-inducible stable human stem cell clones and differentiated them into excitatory cortical-like neurons as determined by morphology and gene expression profile. We characterized the effect of FGF2 treatment on calcium signaling of the neuronal population and found that FGF2 treatment enhanced spontaneous calcium activity. Finally, we used RNA-Seq analysis of FGF2-treated neurons to characterize gene expression changes that may mediate FGF2-enhanced human glutamatergic neuronal activity.
Materials and methods
Cell culture and transfection of human embryonic stem cells H9 embryonic stem cells (ESCs) were obtained from WiCell Research Resources (WiCell, Madison, WI, USA; RRID: CVCL_9773); the control induced pluripotent stem cells (iPSC) line was derived from commercially available human foreskin fibroblasts (MTI Global Systems, Gaithersburg, Maryland, USA; Cat. No. GSC-3002) and reprogrammed using episomal plasmids as described (Okita et al. 2011) . Both ESCs and iPSCs were maintained in feeder-free conditions using Matrigel substrate (Corning; Corning, NY, USA Cat. No. CB40234B), mTeSR8 medium (E8-Stem Cell Technologies, Cambridge, MA, USA; Cat. No. 05940), and passaged every 4-5 days with EDTA as described (Beers et al. 2012) . The H9 ESC line is not a commonly misidentified cell line (iclac.org/databases/crosscontaminations). All human cell culture experiments were approved by the University of Michigan Human Pluripotent Stem Cell Research Oversight Committee and the University of Michigan Institutional Review Board.
Generation of siNeuron hES and hiPSC lines using Tol2 recombinase Stem cells were plated onto Matrigel-coated plates at a density of 1-5 9 10 4 cells per well in the presence of 1 lM Y-26732 (Tocris Bio, Minneapolis, MN, USA; Cat. No. 1254) in E8 media. The following day, the media was changed to E8 alone, and cells were transfected with a total of 2.5 lg of Tol2-plasmids (Balciunas et al. 2006) . Plasmids to be chromosomally integrated contained the Tol2 arms and were derived from the pMiniTol2 parental plasmid (Balciunas et al. 2006) . These plasmids included the pMT-US2-TetOn-internal ribosome entry site-enhanced green fluorescent protein (EGFP) (20% of transfected DNA), pMT-tetracycline response elements-hNeurog2 (20% of transfected DNA), and pMT-US2-puro (5-10%) which were generated from previously described plasmids lacking the minitol integration arms (Huang et al. 2010 . In addition to the integrating plasmids, the transfected DNA contained 40-50% of the pUS2-Tol2 plasmid which expresses the Tol2 recombinase. pUS2-Tol2 was generated by excising the Tol2 coding region from pCMV-Tol2 (Balciunas et al. 2006) and inserting it into the multiple cloning site of the pUS2 plasmid containing the human ubiquitin C promoter. Following transfection of 2.5 lg of mixed plasmid DNA using Mirus LT1 (Thermo Fisher, Waltham, MA, USA; Cat. No. MIR2300), the cells were fed with E8 media after 24 h. At 72 h after transfection, cells were treated with 0.8 lg/mL puromycin in E8 media for 24-48 h followed by growth in E8 media. Approximately 1 week later, colonies of approximately 500 cells were picked manually into individual wells of a 24-well plate. The clones were expanded and replicate cultures were tested for differentiation in the presence of dox.
Induction of siNeurons from human ESCs and iPSC siN lines hESCs and iPSCs were plated on Matrigel-coated six-well plates in mTeSR8 media with 1 lM Y-27632. The following day the cells were treated with 1 lg/mL dox to induce NEUROG2 gene expression. On day 3 when the majority of cells ceased proliferation, the cells were passed into 3N differentiation media (1 : 1 Dulbecco's modified Eagle's medium : F-12/Neurobasal, 1 mM Glutamax, 5 lg/mL insulin, N2 supplement, B27 supplement, 1 mM Minimum Essential Amino acids, b-mercaptoethanol) (Shi et al. 2012) in the presence of 1 lg/mL dox. Cells were fed daily with 3N media until analysis.
Immunocytochemistry
Cells were fixed and immunostained as described . Table S1 . Each sample was assayed in triplicate, and the D-DCT method was used to calculate relative expression levels normalized to GAPDH.
Protein extraction and western blotting analysis
Proteins were extracted as previously described . Equal amounts of protein were electrophoresed and transferred onto a 0.2 lm Nitrocellulose membrane (Whatman, GE Healthcare LifeSciences, Pittsburgh, PA, USA; Cat. No. EP4HYA0010). Membranes were blocked using 5% non-fat dry milk in phosphate-buffered saline containing 2% polyvinylpyrolidone (PVP-40) and 0.1% Triton X-100 for 2 h at 25°C. Primary antibodies were diluted in phosphate-buffered saline supplemented with 0.5% bovine serum albumin and 0.1% Triton X-100 overnight at 4°C. Horseradish peroxidase-conjugated secondary antibodies were used and chemiluminescence was assayed using Data analysis RNA-Seq reads were aligned to the human genome (hg19) using the SubRead aligner (Liao et al. 2013) . Gene-level RNA-Seq counts summaries for each sample were derived by the featureCounts program (Liao et al. 2014 ) based on GenCode 24 annotation (http:// www.gencodegenes.org/releases/24.html). Differentially expressed gene lists for FGF2 treatment datasets were derived from the consensus of limma-voom (Ritchie et al. 2015) and DESeq2 (Love et al. 2014 ) analysis results at multiple testing corrected p ≤ 0.05.
The online DAVID Bioinformatics Resources 6.8 was used to annotate gene lists derived from RNA-Seq analysis (https://david.nc ifcrf.gov/) (Sherman et al. 2007; Huang et al. 2009 ). We assigned the Gene Ontology terms using DAVID analysis to compute the functional categories in 'Biological processes', 'Molecular function', and 'Cell component'. Hierarchical clustering was performed using the CRAN R hclust function using default parameters (https:// cran.r-project.org/).
Statistical analysis
Statistical analysis of calcium imaging and qRT-PCR data were done with Microsoft Excel. Standard deviations of the mean were reported. Statistical significance was assessed with two-tailed Student's t-test with p < 0.01.
Multiwell MEA plates and cell culture The multielectrode array (MEA) recording protocol was followed as described (Bardy et al. 2015) . Briefly, 96-well MEA plates were used with each well containing eight microelectrodes and four ground electrodes for a total of 768 channels (Axion Biosystems, Atlanta, GA, USA). Prior to culture, each well was coated with filter sterilized 0.2% polyethyleneimine (PEI) in 0.1 M sodium borate buffer pH 8.4. The PEI solution was removed and washed with sterile water four times. H9-N2 cells were plated at a density of 2 9 10 5 cells/mL on Matrigel-coated six-well plates in mTESR1 media with 1 lM Y-27632. The cells were treated with 0.5 lg/mL dox to generate neurons and 2 days later passaged onto PEI coated MEA plates. A 5 lL droplet of cell suspension (150 000 cells) containing 10 lg/ mL laminin was added to the center of each well directly over the electrode area. The cells were incubated for 1 h prior to addition of 3N media. The media was replaced daily with 3N+dox. After 7 days, the media was switched to BrainPhys media (StemCell Technologies, Cambridge, MA, USA; Cat. No. 5790) with 25 ng/ mL brain derived neurotrophic factors and 25 ng/mL glial cell linederived neurotrophic factor and half of the media was replaced every other day. Spontaneous activity was recorded daily for 5 min at 37°C using the MEA system (Axion) and the associated software Axis 2.1. All the channels were sampled together and recorded. Standard settings were used with the threshold spike detector set at 69 standard deviation (Bardy et al. 2015) .
Data accessibility RNA-Seq data are available at NCBI GEO (GSE92971).
Study design
This study was not pre-registered, no blinding of results was performed and outcomes were exploratory.
Results
Generation of stable inducible glutamatergic neurons from hESCs Previous methods to generate post-mitotic glutamatergic neurons from human pluripotent stem cells have used either small molecule induction or over-expression by viral transduction. In order to minimize experimental variability, we used a Tol2 transposon based gene transfer system widely used in zebrafish to generate stable human cell lines essentially as described previously (Meir et al. 2011) . We sought to generate hESC lines with chromosomally integrated vector sequences that would allow for doxycycline (dox) induction of human NEUROG2 gene expression. Lipid transfection of H9 hESCs showed that the transient coexpression of an expression vector for the Tol2 recombinase increased the generation of stable puromycin resistant colonies 100-fold and the majority of these colonies stably expressed a co-transfected EGFP marker protein after puromycin selection ( Figure S1 ). Furthermore, the expression of EGFP was stable for at least 20 passages in the absence of puromycin (data not shown).
In order to generate stable stem cell clones capable of differentiating into glutamatergic neurons (siNeurons), we constructed three pMini-tol2 derived vectors containing the minimal inverted terminal repeats required for gene transfer (Fig. 1a) . The MT-US2-TetON-iRES-EGFP plasmid expresses the TetON transcriptional regulator protein and also EGFP . The MT-tetracycline response elements-hNeurog2 plasmid expresses the human NEUROG2 protein with its 3 0 UTR in a dox-dependent manner while the MT-US2-puro contains the coding region for puromycin N-acetyl-transferase. These plasmids were used to generate stable puromycin-resistant H9 clones as described (Materials and Methods).
Colonies of puromycin-resistant H9 cells demonstrating homogenous EGFP expression were isolated and screened for differentiation after treatment with dox. Of the 24 clones isolated, 16 showed at least partial inhibition of cell growth after 2 days of dox treatment and four clones showed extensive neurite generation. One of these clones designated as H9-N1 was studied in greater detail. The H9-N1 clone showed expression levels of key pluripotency genes (NANOG, POU5F1, and SSEA4) that were indistinguishable from parental H9 cells (data not shown). This H9-N1 line was also euploid as determined by SNP-ChIP hybridization analysis (data not shown).
Upon treatment with dox, the H9-N1 cell line showed reduced cell growth and morphological changes after 2 days. After 11 days of dox treatment, the cells adopted a neuronal morphology with long processes. During the 11-day time course, there was a dox-dependent activation of NEUROG2 mRNA and protein (Fig. 1c-e ) that preceded rapid differentiation of the H9-N1 stem cells as demonstrated by the loss of pluripotency markers such as POU5F1 and NANOG (Figure S2) . At the end of 11 days of dox treatment, the cells also positively immunostained for neuronal markers including MAP2, NEUN, MAPT (TAU), SYN, and PSD95 genes (data not shown).
To understand the specific transcriptional alterations that were involved in the dox-induced differentiation, time (vGLUT2) showing the enrichment of marker upon induction, whereas the hESCs are almost devoid of the glutamatergic marker.
course samples (Fig. 2a) were subjected to RNASeq analysis. This analysis identified over 2600 genes that were induced and over 1900 genes repressed by dox treatment (fold change > 5). The untreated H9-N1 cells showed very low expression of genes commonly associated with neural development, synaptic signaling, and neuronal differentiation. In contrast, many neuronal marker genes were significantly up-regulated in the dox-treated H9-N1 siNeurons. For example, MAP2 and SYN genes demonstrated 50-and 20-fold increases, respectively. A selected list of highly induced and repressed genes over the time course is shown in Table 1 . Among the induced genes were glutamate receptors (GRIA2, GRIK1), neuron-specific microtubule associated genes (DCX, MAPT, GAP43), synaptic vesicle associated genes (SLC17A6), and voltage gated sodium channel gene (SCN3A). Many of the highly repressed genes were associated with the pluripotency markers (NANOG, POU5F1), inhibition of transcription (ID3), and cell adhesion genes (CDH1, EPHA1, ITGB5).
Gene ontology (GO) enrichment analysis demonstrated that the most highly induced genes (50-fold or greater) were associated with nervous system development genes (e.g. SCN3B, NEUROD2, NEURL1, DCX), axon guidance (e.g. RELN, EPHA5, NTRK1, CDK5R2) and chemical synaptic transmission (e.g. GRIK1, GRIK2, SYT5, SCNG) ( Fig. 2b and c, Table S2 ). The p-values associated with processes occurring later in maturation of neurons such as glutamate secretion and synapse assembly were highly significant (Fig. 2b ). These results demonstrate that NEUROG2 drives an extended program of neuronal differentiation of hESCs. The GO analysis for the genes that were induced 5-fold or higher in the hESCs was most significantly associated with cell-cell signaling (e.g. FGF17, FGF21, MLN), cell adhesion (e.g. ACAN, CDH15, FREM3), and cell differentiation (e.g. ONECUT3, GADD45G, SOX15). The normalized gene expression values of NEUROG2 and vGLUT2 from the RNA-Seq analysis showed significant expression of NEU-ROG2 and vGLUT2 only after dox treatment (Fig. 2d and e) .
Guided by the RNA-Seq analysis, the highly induced transcripts for neural fate commitment, synaptic machinery components, and glutamatergic markers were confirmed using real-time quantitative PCR as shown in Fig. 3(a) . The synaptic gene SYN was induced 50-fold over the time course of 11 days, whereas vGLUT2 was increased over a 1000-fold. The neuron-specific cytoskeletal genes DCX and MAPT were also highly induced with 500-fold and 250-fold inductions, respectively. The proneural activity of NEUROG2 initiates a gene transcriptional program directing the cells to exit the cell cycle and activate other downstream transcription factors, such as NEUROD1, converting stem cells to a homogenous population of glutamatergic neurons. Genes associated with synapse assembly (NRXN1, NLGN1), release of transmitters (BSN/CHGA-B), and voltage gated sodium and potassium channel genes (SCN1A, KCNQ2) were also highly induced in H9-N1 siNeurons over the time course (data not shown). Consistent with the transcriptional changes, differential protein expression of the neuronal proteins vGLUT2, SYN, PSD95, and MAPT was also observed by immunoblot analyses (Fig. 3b) .
Characterization of siNeurons expressing GCaMP6F to monitor real-time calcium changes in culture Genetically encoded calcium sensors are important tools to study the functional activity of neurons. In order to probe the functionality of the siNeurons, GCaMP6f was used as a calcium indicator and the vector MT-CAG-GCaMP6f-MT and a MT-US2-TetON-internal ribosome entry site-mCherry plasmid (Fig. 4a ) was used to generate stable lines in the H9 hESCs in a manner similar to that described above for the H9-N1 cell line. Among the 24 clones selected based on uniform mCherry expression, we selected two clones (H9-N2 and H9-N3) that also showed high uniform GCaMP6f expression for further analysis. A similar differentiation scheme to that used for H9-N1 differentiation (Fig. 1b) was used to study the H9-N2 and H9-N3 siNeurons derived from these cells except that dox treatment was discontinued after 6 days (Fig. 4b) . Immunostaining of these cells showed that at the end of 11 days of differentiation 100% of the cells were MAP2+/TUJ1+ (Fig. 4c) . A hallmark of neuronal identity is the post-mitotic nature of the cells. As dox treatment induces NEUROG2 and activates a transcriptional program, the cells exit the cell cycle after 2 days of dox treatment while committing to a neural fate. By the end of day 6, the vast majority (98.8%) of cells were post-mitotic as quantified by the number of cells capable of incorporating EdU during the cell cycle ( Fig. 4d and e) . Upon qRT-PCR characterization of these cells for gene expression, the cells homogenously expressed the proneural transcription factor (NEUROG2), neuronal markers (DCX), synaptic markers (SYN), signaling markers (CAMKIIA, CAMKIIB), and glutamatergic markers (vGLUT1, vGLUT2) in the two independent cell lines ( Fig. 4f and data not shown).
To study the functional activity of the siNeurons, calcium signaling in the cells was examined. Very little change in siNeuron cytoplasmic calcium was observed by fluorescence microscopy in the 3N differentiation media. However, beginning at day 7 following dox treatment a greater number of cells displayed spontaneous calcium transients in an imaging buffer (EM buffer) used previously for calcium imaging of rat cortical neurons in culture (Tibau et al. 2013) (Fig. 5a and b) . This increase in the number of calcium transients correlated with increased activity observed on multielectrode array (MEA) recordings, which was first observed after 5 days of dox treatment. The MEA spontaneous activity increased gradually up to 21 days following dox treatment (Fig. 5c ). While only a low percentage of siNeurons showed spontaneous calcium transients in EM buffer (< 3%) at 12 days of differentiation, the fraction of cells displaying spontaneous calcium transients increased 20-fold following a pre-incubation with 2.5 mM glutamine (Gln). This increase in observed calcium transients was dependent on extracellular calcium in the imaging buffer (Fig. 5b) . Furthermore, these calcium transients were partially blocked with kynurenic acid, suggesting that the calcium transients induced by Gln pretreatment are at least partially mediated by NMDA receptors (Fig. 5b) . This finding is also consistent with an increase in transcription of the GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, and GRIN3A genes in siNeurons observed by RNA-Seq (Table S2 ). If cells incubated with 2.5 mM glutamine and EM buffer were allowed to recover in 3N media, a time-dependent induction of FOS was seen after the spontaneous calcium transients were observed (Fig. 5d) suggesting that the calcium transients resulted in transcriptional regulation of FOS. This notion would be consistent with the induction of CAMKIIA and CAMKIIB in siNeurons (Fig. 3) .
Functional effects of FGF2 treatment of siNeurons
In order to determine if FGF2 treatment altered the spontaneous calcium transients, we included 20 ng/mL FGF2 in the culture media during differentiation. When FGF2 was included for the first 6 days of dox treatment and the cells were imaged with 2.5 mM Gln pre-treatment, no significant difference in calcium transients was observed between the control and FGF2-treated cells (Fig. 5e) . However, when H9-N2 and H9-N3 cells were differentiated for 6 days in the absence of FGF2 and then FGF2 was added to the media for an additional 6 days, a significant increase in spontaneous calcium transients was observed. The fraction of the post-mitotic siNeurons showing calcium transients increased from 21% in the absence of FGF2 to 44% in the presence of FGF2 (Fig. 5e ). MEA recordings show that the H9-N2 cells in the presence of FGF2 have a significantly higher spike frequency (Fig. 5e ).
Synaptic signaling genes are activated in siNeurons upon treatment with FGF2
To determine the molecular basis of FGF2-enhanced spontaneous activity observed in siNeurons, the H9-N2 and H9-N3 cells were treated with dox in the absence or presence of FGF2 over a time course similar to that used in the calcium imaging studies (Fig. 6a) . One treatment of siNeurons (H9-N2 and H9-N3) was for 6 days with dox in the presence or absence of 20 ng/mL FGF2. A second set of siNeurons was grown for 6 days with dox only and then cultured for an additional 6 days in the presence or absence of FGF2. RNA was isolated from these eight samples (H9-N2 at 6 days with and without FGF2, H9-N2 at 12 days with and without FGF2, H9-N3 at 6 days with and without FGF2, and H9-N3 at 12 days with and without FGF2). Bioinformatic analysis of the RNA-Seq from the 6 days samples showed that no genes were significantly altered in the two cell lines by FGF2 treatment. However, for the 12 days samples, 834 genes were found to be differentially expressed after FGF2 treatment by DESeq2 analysis (p < 0.05). A selected list of highly induced and repressed genes are outlined in Gene ontology enrichment analysis was done for the genes that were induced fivefold or higher in response to FGF2 treatment using DAVID. The GO terms with the highest pvalues and fold enrichments were attributed to signal transduction, positive regulation of transcription, mitogenactivated protein kinase (MAPK) cascade, and receptor tyrosine kinase signaling ( Fig. 6b and c) . Normalized gene expression of the highly induced transcription factor gene ETV4 as determined by RNA-Seq showed that there was no significant change in the normalized counts during differentiation and the induction was mediated by FGF2 at day 12 (Fig. 6d) . In contrast, the normalized counts for SPRY4 expression decreased during differentiation. It has been reported previously that the SPRY2 and SPRY4 genes of the sprouty gene family are highly expressed in hESCs and decrease with differentiation (Felfly and Klein 2013) . However, in the presence of FGF2 at day 12, expression of SPRY4 was induced (Fig. 6e) . The neuronal specific gene NRXN3 increased with differentiation but the fold induction was significantly higher when treated with FGF2 (Fig. 6f) . The regulation of these genes was confirmed by qRT-PCR in biological triplicates in the two independent cell lines ( Fig. 6g-i) . The regulation of NRXN3 by FGF2 was small but it was replicated in our experiments with statistical significance (Student's t-test; p < 0.01). Other genes that were found to be regulated by FGF2 are DUSP6, SYT2, and GALR1 that were also confirmed by qRT-PCR ( Figure S3 ).
FGF2 regulates gene transcription via Ras/MAP kinase pathway
In order to characterize the signal transduction pathway leading to gene regulation of the candidate genes identified by RNA-Seq after FGF2 treatment, we used a shorter 24 h time course of FGF2 treatment. The observed induction of EGR1 and NXF1 in the RNA-Seq analysis suggested that immediate early genes were regulated by FGF2 in siNeurons. As a critical immediate early gene, transcription of FOS has been studied extensively and it has been clearly established that FOS plays a critical role in establishment of neuronal circuits (Flavell and Greenberg 2008) . Upon acute treatment of H9-N2 and H9-N3 siNeurons with 2 ng/mL FGF2 for up to 24 h ( Fig. 7a and b) , we found by qRT-PCR that the immediate early gene transcription factors FOS, EGR1, and NXF were induced 2000-fold, 500-fold, and 15-fold, respectively, within 60 min of treatment with FGF2. These transcription factors preceded a later 200-fold induction of SPRY4 after 8 h, and ETV4 as well as KITLG were induced after 12 h of FGF2 treatment. The neuron-specific genes that we identified from our RNA-Seq analysis, NRXN3, SYT2, and GALR1, showed a 3-to 4-fold induction after 12 h of independent cell lines at day 6 and day 12 respectively. No significant difference was seen at day 6 but the expression level increased (ETV4, NRXN3) or decreased (SPRY4) significantly in the presence of FGF2 at day 12. (g-i) Quantification of mRNA levels for the genes PEA3 (ETV4) (p = 0.00004, p = 0.00008), SPRY4 (p = 0.00018, p = 0.006), and NRXN3 (p = 0.0041, p = 0.009) in biological triplicates of two independent cell lines showing a significant increase in expression in the presence of FGF2; **p < 0.01. FGF2 treatment. The immediate early gene expression changes with FGF2 treatment by qRT-PCR were correlated with the protein products seen after western blotting as well as immunostaining (Fig. 7c, Figure S4 ). The FGF2-mediated increase in NRXN3 mRNA was reproducible and replicated in our study, but no increase in NRXN3 protein was observed by either western blotting or immunostaining (data not shown). The neurexins NRXN1 and NRXN2 also increase in expression in siNeurons over the differentiation time course but only the expression of NRXN3 is increased by FGF2 treatment ( Figure S5 ). These acute responses to FGF2 treatment were also confirmed using a completely independent control iPSC siNeuron line generated in a manner identical to H9-N2 and H9-N3 cells ( Figure S6) .
The strong induction of FOS in the presence of FGF2 was essentially abolished by pre-treating the cells with a FGFR1 inhibitor, PD173074, or by pre-treating with the MAPK inhibitor, PD098059 (Fig. 7d and e) . These results suggest that the immediate early gene induction by FGF2 in siNeurons is mediated through the classical FGFR activation pathway and the downstream Ras/MAPK pathway. FOS mRNA was also induced by feeding siNeurons with fresh media in the absence of any external growth factor. A maximal induction of FOS by FGF2, required that the media remain unchanged prior to FGF2 addition ( Figure S7) . Importantly, the FGF2-induced FOS activation was significantly enhanced in differentiated siNeurons compared to the undifferentiated cells in 3N media (Fig. 7f) . The siNeurons showed a maximal 600-fold induction of FOS mRNA with FGF2 treatment while the undifferentiated cells showed only a fivefold induction of FOS mRNA. This increased sensitivity of siNeurons to FGF2 suggests that a fundamental change in FGF2 signaling occurred during siNeuron differentiation.
Discussion
MDD is a human brain disorder without a clear molecular mechanism; however, the potential role of FGF2 in MDD is supported by post-mortem human studies and animal behavioral experiments (Turner et al. 2016) . The number of genes contributing to MDD susceptibility and their relative contribution is still highly debated (Flint and Kendler 2014) . In any human brain disorder, a molecular level analysis of gene expression can be the key to understanding the underlying pathophysiology of the disease. The use of hiPSCs in monogenic disorders like Rett syndrome has been advantageous in understanding the role of the gene, identifying potential druggable targets, and developing drug screening systems (Marchetto et al. 2010) . However, in a polygenic mood disorder like MDD, the combinatorial interactions of participating genes can be difficult to study. Furthermore, the multiple cell types seen during in vitro neural differentiation of human stem cells and the variability in their yields can confound genetic analysis. Here, we decided to focus on the effects of FGF2 on a single cell type to determine the possible neurochemical consequences of the altered FGF2 expression levels seen in post-mortem human brain studies.
Directed neuronal differentiation using transcription factors has been widely applied to generate induced neurons (iNs) to study human neurological disorders. These iN cultures are generally more homogeneous and more rapidly differentiating than neuronal cultures derived with small molecules altering endogenous signaling components (Masserdotti et al. 2016 ). Zhang and colleagues described a method of generating a relatively pure population of excitatory neurons by lentiviral transduction of both the rtTA transcriptional regulator and tetracycline responsive promoter into hESCs (Zhang et al. 2013) . Viral transduction of NEUROG2 together with puromycin selection to increase purity of cultures yielded populations of iNs that were TUJ1/ MAP2+ (90%) within 14 days. iNs exhibited excitatory functional synapses when co-cultured with mouse cortical neurons after 3 weeks. Single cell qRT-PCR analysis demonstrated induced expression of many neuronal genes that are not expressed in stem cells, including genes for glutamate receptors, vesicular glutamate transporters, and synaptic proteins. In this study, a Tol2 transposon system (Meir et al. 2011 ) was used for gene transfer of NEUROG2 in H9 hESCs and hiPSCs. The vectors containing the Tol2 transposon inverted terminal repeats were designed for integration into the chromosome in the presence of a Tol2 recombinase. The use of Tol2-based chromosomal integration allows for easy generation of clones that are stable over > 20 passages. After treatment with dox, the cells adopted a neuronal morphology within 2 days, exited the cell cycle, and showed detectable spontaneous calcium activity and action potentials within a week. RNA-Seq analysis of differentiated siNeurons showed large increases in the expression of pan-neuronal markers (DCX, MAP2), neuronal signaling proteins (CAMKIIA, CAMKIIB), synaptic proteins (SYN, DLG4), and cell-type specific glutamatergic neurotransmission proteins (vGLUT2, GRIA2, GRIK1). Furthermore, specific cortical neuronal markers such as FOXG1 and SATB2 were also induced.
In calcium imaging experiments, the siNeurons (H9-N2 and H9-N3) displayed spontaneous intracellular calcium fluctuations which were enhanced after Gln pre-treatment. The spontaneous calcium fluctuations resulted in induction of mRNA and protein for the immediate early gene, FOS. The spontaneous calcium fluctuations of differentiated H9-N2 and H9-N3 siNeurons were partially mediated by glutamate receptors since the spontaneous calcium activity was reduced significantly by kynurenic acid.
We used the spontaneous calcium activity of siNeurons to determine if FGF2 altered their function. We hypothesized that FGF2 would increase the glutamatergic signaling in human neurons based on the previous literature that shows FGF2 increases glutamatergic signaling in rat neurons (Li et al. 2002) . Our results revealed that FGF2 treatment enhanced the spontaneous calcium activity of post-mitotic H9-N2 and H9-N3 neurons at day 12 after initiation of differentiation. While FGF2 has been demonstrated to have profound effects on neurogenesis, the majority of these effects are on mitotic neural stem cells and neuronal precursors (Palmer et al. 1995) . In our experiments, FGF2 effects are on post-mitotic siNeurons and FGF2 alters their synaptic function.
To understand the transcriptional changes that regulate the increase in synaptic activity of neurons in the presence of FGF2, we identified genes that were responsive to FGF2 as well as the signaling mechanism of action of FGF2. In agreement with the time course of FGF2 effects on calcium imaging, no genes were responsive to FGF2 in RNASeq analysis after 6 days. However, after 12 days, over 800 genes were found to be differentially regulated by FGF2. The gene that showed the highest induction by FGF2 was ETV4 (PEA3) which encodes a transcription factor that has been shown to be regulated by FGFs in mouse development, zebrafish development, and NIH3T3 cells (Vinothkumar et al. 2008; Mao et al. 2009 ). A second highly induced gene in siNeurons was a member of the sprouty family, SPRY4, which is an antagonist of receptor tyrosine kinase signaling (Mason et al. 2006) . The expression of SPRY4 is known to decrease with differentiation of hESCs (Felfly and Klein 2013; Lee et al. 2016) . Possibly because of the low expression of SPRY4 in differentiated neurons, the H9-N2 and H9-N3 siNeurons showed increased sensitivity to FGF2 in terms of FOS gene induction. Decreased SPRY4 is expected to cause increased receptor tyrosine kinase signaling in response to growth factors (Felfly and Klein 2013) . Like SPRY4, the down-regulation of DUSP6 during siNeuron development and induction by FGF2 at day 12 was also seen in our studies. FGF2 regulation of DUSP6 has also been shown in NIH3T3 cells, zebrafish and mouse development (Li et al. 2007 ). The induction of DUSP6 is through the MAPK pathway and it produces feedback inhibition of FGF signaling (Ekerot et al. 2008) .
Another FGF2-regulated gene that was identified by RNA-Seq was ANOS1 encoding an extracellular matrixassociated protein. ANOS1 was repressed upon FGF2 treatment. Mutations in ANOS1 (KAL1) gene cause Xlinked Kallmann syndrome type I and mutations in the FGFR1 gene cause Kallmann syndrome type II. A strong similarity of patient phenotypes has suggested a functional interaction between ANOSI and FGFR1 genes (Salenave et al. 2008; Sarfati et al. 2015) . The precise mechanism remains unclear but the functional interaction has been shown in developing optic nerve and olfactory neuroblasts (Hu et al. 2009) .
A distinct set of FGF2-regulated genes that were expressed only in neurons and have not been reported previously included NRXN3, SYT2, and GALR1. The NRXN3 gene encodes a receptor molecule that acts as a presynaptic organizer of synapse function. This gene has been associated in genome-wide association studies with ASD (Vaags et al. 2012) , schizophrenia (Novak et al. 2009; Brown et al. 2011) , bipolar I disorder (Kuo et al. 2014) and MDD (Shyn et al. 2011) . Neurexins have been widely studied for their activities in presynaptic vesicle release and post synaptic density assembly. Their impact has also been shown on glutamatergic and GABAergic synapses (Graf et al. 2004) . It is possible that the transcriptional induction of NRXN3 is at least partially responsible for the enhancement of spontaneous activity of siNeurons upon treatment with FGF2. A second neuronal gene that was found to be regulated by FGF2 is the galanin receptor I gene (GALR1). Rodent experiments suggest that the neuropeptide galanin (GAL) and its three G-protein coupled receptors GALR1-3 are involved in mood regulation (Juhasz et al. 2014) . Human genetic studies have shown the involvement of the galanin system in pshychiatric disorders and MDD (Barde et al. 2016) . GAL and GALR1 have CRE binding sites (Zachariou et al. 2001) which could respond to the FGF2 activated Ras/ MAP kinase pathway and phosphorylation of cAMPresponse element binding protein.
There is evidence that FGF2 treatment improves long term memory in rats (Graham and Richardson 2009) , enhances neurogenesis (Raballo et al. 2000) , and improves behavior in models of MDD (Turner et al. 2008) . In general, the intracellular mechanisms of action and the cell types involved in these effects remain unclear. The aim of our study was to identify the potential signaling mechanisms and target genes that are specifically altered by FGF2 in postmitotic excitatory neurons. Our findings suggest that siNeurons represent a tractable model to further explore the detailed mechanisms of FGF2 regulation of neuronal gene expression and synaptic function. 
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